AHA Scientific Sessions 2026 Abstract · Nov 2, 2026

Exploration of Telomere Length Attrition in Children and Adults with Congenital Heart Disease

By Wong-Siegel J, Lewis M, Reilly MP et al.

Background: As the congenital heart disease (CHD) population continues to grow, an excess incidence of cancer, as well as other end-organ morbidities, has been observed. This increased burden may be related to several factors- including surgical interventions, radiation exposure from diagnostic and therapeutic management, and underlying cardiac physiology. It has been suggested these stressors can result in accelerated aging. A hallmark of aging, telomere length (TL) is associated with increased risk of cancer and other end-organ morbidities. Yet essentially no studies have examined TL in CHD patients and potential risk factors for TL shortening. We investigated relative TL trends in a sample of pediatric and adult CHD patients. Methods: Available biospecimens for CHD patients and age- and, when possible, sex-matched controls were obtained from the Columbia University Biobank (CUB). Relative TL (RTL) from isolated genomic DNA was measured using a quantitative polymerase chain reaction assay. Additional baseline patient characteristics, including CHD diagnosis, procedural history, and presence of end-organ morbidities were collected. Results: Overall, 104 patients were included with 49 patients diagnosed with CHD and 55 controls without CHD or other significant diagnoses associated with telomere biology disorders or end-organ dysfunction. CHD patients ranged in age from 4-80 years old with 55% having complex CHD. For the entire cohort, RTL was similar between CHD patients and age-matched controls (p= 0.14) and in the sub-group with simple CHD lesions (p= 0.83). However, patients with complex CHD lesions had significantly shorter RTL compared to age-matched controls (average RTEL difference (ΔRTL)= -0.111, p= 0.006). Patients who had more than two cardiac catheterizations, including 25% with a simple CHD lesion, tended to have shorter RTL by age at collection (p= 0.063) and significantly shorter RTL than age-matched controls (ΔRTL= -0.151, p= 0.028, Figure 2), a finding not replicated among CHD patients who had 0-1 cardiac catheterizations (p= 0.85). RTL tended to be shorter among CHD patients with at least one documented end-organ morbidity but did not reach statistical significance (p= 0.063). Conclusion: This is the first study to demonstrate accelerated telomere attrition in CHD patients. This difference appears driven largely by those with complex lesions and those having undergone more than two cardiac catheterizations as a proxy for radiation exposure. Utilization of TL may be a promising biological marker for CHD patients at risk for development of end-organ morbidities, providing an opportunity for changes in management practices to reduce this risk. Larger prospective studies of CHD patients will be important to capture robust management data, including radiation exposure, as well as incidence of morbidities and mortality.

doi.org/10.1161/circ.154.suppl_1.9706Populations

AgingResearch.News